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To investigate the correlation between postmenopausal osteoporosis (PMO) and the pathogenesis of periodontitis, ovariectomized
rats were generated and the experimental periodontitis was induced using a silk ligature. The inflammatory factors and bone
metabolic markers were measured in the serum and periodontal tissues of ovariectomized rats using an automatic chemistry
analyzer, enzyme-linked immunosorbent assays, and immunohistochemistry. The bone mineral density of whole body, pelvis, and
spine was analyzed using dual-energy X-ray absorptiometry and image analysis. All data were analyzed using SPSS 13.0 statistical
software. It was found that ovariectomy could upregulate the expression of interleukin- (IL-)6, the receptor activator of nuclear
factor-𝜅B ligand (RANKL), and osteoprotegerin (OPG) and downregulate IL-10 expression in periodontal tissues, which resulted
in progressive alveolar bone loss in experimental periodontitis. This study indicates that changes of cytokines and bone turnover
markers in the periodontal tissues of ovariectomized rats contribute to the damage of periodontal tissues.
1. Introduction
Periodontitis is a chronic and destructive disease of the
periodontium caused by various factors such as periodontal
pathogens; it is commonly characterized by inflammation of
periodontal tissue and alveolar bone absorption [1].
Osteoporosis is a systematic, bone metabolism-related
disease with bone loss and destruction of fine bone structures
that increases bone fragility and the risk of fracture. It is
extremely common among the elderly, particularly in post-
menopausal women. Postmenopausal osteoporosis (PMO)
is osteoporosis that occurs after menopause because of the
decrease in estrogen. The ovariectomized rat is a useful
animal model for the study of osteoporotic bone related
diseases caused by estrogen deficiency. This model exhibits
a progressive loss of bone matrix through a process similar to
what occurs during PMO [2, 3].
Epidemiologic research shows that chronic periodonti-
tis is related to osteoporosis. Several studies have already
indicated that insufficient estrogen is closely related to peri-
odontitis and osteoporosis. Recently, an increasing number
of researchers suggest that PMO promotes periodontitis
[4–6]. It has been demonstrated that periodontal bacteria
promote the alveolar bone loss in periodontitis. The invasion
of periodontal bacteriamay reduce bone density and enhance
osteoclastic activity by releasing toxins and/or inflammatory
cytokines [1].These cytokines believed to be involved in alve-
olar bone remodeling are also highly expressed in PMO [7].
Since estrogen inhibits the expression of the inflammatory
cytokines, it might be that larger amounts of these cytokines
are presented in an inflammatory alveolar bone with estrogen
deficiency. Therefore, estrogen deficiency may contribute to
the alveolar bone absorption in periodontal disease, either
by reducing the bone mass of alveolar bone or by causing
increased expression of inflammatory cytokines. However,
the underlying mechanisms are still not clear.
The homeostasis of bone tissues is controlled by the
dynamic balance between osteoblastic bone formation and
osteoclastic bone resorption. An imbalance between these
cell activities contributes to various bone metabolic dis-
eases. Osteoclast activation and maturation are regulated by
three recently discovered proteins: the receptor activator of
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nuclear factor-𝜅B (RANK), RANK ligand (RANKL), and
osteoprotegerin (OPG) [8, 9]. The binding of RANKL to
RANK on preosteoclasts initiates the differentiation and
proliferation of these cells and promotes osteoclast fusion and
activation. Moreover, the activation of the RANKL-RANK
pathway suppresses osteoclast apoptosis, thereby increasing
the number of activated osteoclasts. On the other hand, OPG
inhibits this pathway by binding to RANKL. Thus, the afore-
mentioned proteins play essential roles in the development
and maintenance of bone tissues [10, 11].
During the past decade, considerable evidence suggests
that estrogen prevents bone loss by blocking the production
of proinflammatory cytokines, such as interleukin-1 (IL-1),
IL-6, IL-10, tumor necrosis factor- (TNF-) 𝛼 in bone marrow
and bone cells [12, 13]. The main consequence of increased
cytokine production in the bonemicroenvironment is expan-
sion of the osteoclastic pool because of increased osteoclast
formation and their extended lifespan. To investigate the
potential mechanism of PMO in periodontitis initiation and
progression, we investigated the correlation between PMO
and the pathogenesis of periodontitis in rats under estrogen
deficiency (ovariectomy). The expression of IL-1𝛽, IL-6, IL-
10, TNF-𝛼, OPG, RANKL, andMMP-8 in periodontal tissues,
with or without osteoporosis, was analyzed using enzyme-
linked immunosorbent assays and immunohistochemistry.
2. Materials and Methods
2.1. Animals. All animal care and study protocols were
approved by the Animal Care and Use Committee of Fujian
Medical University. A total of 24 three-month-old female
Sprague-Dawley (SD) rats (220–260 g) were purchased from
an animal resource centre (SLAC Laboratory Animal Co.
Ltd., Shanghai, China).The rats weremaintained in an animal
room with 12 h day-night cycles, an ambient temperature of
22 ± 2
∘C. Food and water were provided ad libitum.
2.2. Surgical Protocols. Anesthesia was achieved through
intramuscular injection of 4 : 1 ketamine-xylazine solution
at 0.15mL/100 g body weight. Bilateral ovariectomy was
performed in 12 rats as previously described [14]. Sham
surgeries were performed in other 12 rats when the ovaries
were exposed but not removed. The rats were randomly
divided into four groups: Group I (𝑛 = 6), sham-operated
(SHAM); Group II (𝑛 = 6), ovariectomy (OVX); Group III
(𝑛 = 6), SHAM + experimental periodontitis (EP); Group IV
(𝑛 = 6), OVX + EP. At 10 weeks after surgery, EP was induced
by placing 4-0 sterile silk ligatures around the cervix of the
left upper second molar in Groups III and IV.
2.3. Tissue and Serum Preparation. At 2 weeks after ligation,
all rats were euthanized using an overdose of anesthetic.
Blood samples were taken after euthanizing the rats. The
serumwas separated by centrifugation for 5min at 3,000 rpm.
The samples of the three molars including the left maxillary
were dissected, fixed for 48 h using 4% paraformaldehyde
in phosphate-buffered saline (PBS) at 4∘C, decalcified, dehy-
drated, and then embedded in paraffin blocks.
2.4. Measurement of Bone Mineral Density. At 2 weeks after
ligation, all rats were euthanized through an overdose of
anesthetic. The dual-energy X-ray absorptiometry (DEXA)
was used to measure the bone mineral density (BMD) of the
whole body, the pelvis, and the spine.
2.5. Measurement of Alveolar Bone Loss. Alveolar bone loss
was evaluated using the following indices: (𝐴) the area of
the periodontal ligament in the root furcation of the upper
second molar, with a vertical distance of 1mm to the top
of the furcation; (𝐵) the distance from the cement-enamel
junction (CEJ) to the alveolar bone crest (ABC) within the
placement zone of the ligature and the contralateral zone.
Figure 1 shows themethod of these measurement indices and
the results were analyzed using Image-pro Plus 6.0 (Image-
pro Plus, Media Cybernetics, Inc., USA).
2.6. Enzyme-Linked Immunosorbent Assays. The serum levels
of BAP, TRAP 5b, IL-1𝛽, TNF-𝛼, and IL-6 were assayed
by enzyme-linked immunosorbent assay techniques using
commercial kits (R&D Systems, Minneapolis, MN, USA),
according to the manufacturers’ recommendations. Each
serum cytokine was determined through its optical density,
recorded at 450 nm using a microplate spectrophotometer.
2.7. Immunohistochemical Analysis. Tissue sections (5𝜇m)
were prepared for immunohistochemical study. After
deparaffinization and rehydration, the sections were heated
in citrate buffer using a pressure cooker to unmask the
antigenicity of antigens masked by aldehyde fixation. They
were then washed with PBS and treated with 3% hydrogen
peroxide for 10min to block endogenous peroxidase
activity. The sections were incubated for 60min at room
temperature with primary antibodies: goat polyclonal
anti-IL-6 (SC-1265; Santa Cruz Biotechnology, Inc., Santa
Cruz, CA, USA), goat polyclonal anti-RANKL (SC-7628;
Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA), goat
polyclonal anti-OPG (SC-8468; Santa Cruz Biotechnology,
Inc., Santa Cruz, CA, USA), rabbit polyclonal anti-IL-1𝛽
(SC-7884, Santa Cruz Biotechnology, Inc., Santa Cruz, CA,
USA), rabbit polyclonal anti-TNF-𝛼 (SC-8301, Santa Cruz
Biotechnology, Inc., Santa Cruz, CA, USA), rabbit polyclonal
anti-MMP-8 (2145-1, Epitomics Inc., Epitomics, CA,USA), or
rabbit polyclonal anti-IL-10 (bs-0698R, Beijing Biosynthesis
Biotechnology, Beijing, China). After washing in PBS, the
sections were incubated for 15min at room temperature with
one of the following secondary antibodies: HRP polymer
anti-rabbit (KIT-5004, Maixin-Bio, Fuzhou, China) to detect
IL-1𝛽, TNF-𝛼, MMP-8, and IL-10 positive cells. Samples
used to detect IL-6, RANKL, and OPG were incubated for
10min with biotinylated rabbit antigoat immunoglobulin
(KIT-9709, Maixin-Bio, Fuzhou, China) and then incubated
for 15min with peroxidaseconjugated streptavidin at room
temperature. After washing in PBS and visualizing using
3,3-diaminobenzidine for 5min, all the sections were
counterstained with hematoxylin for 20 s and then rinsed
in running water. Finally, the sections were dehydrated in
ascending concentrations of alcohol, cleared with xylene, and
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Table 1: BMD values of whole body, pelvis and spine in four groups.
Groups Whole body (g/cm2) Pelvis (g/cm2) Spine (g/cm2)
SHAM 0.173 ± 0.005 0.170 ± 0.004 0.158 ± 0.005
OVX 0.155 ± 0.008∗ 0.154 ± 0.008∗ 0.143 ± 0.008∗
SHAM + EP 0.170 ± 0.005 0.168 ± 0.005 0.159 ± 0.006
OVX + EP 0.157 ± 0.010∗∗ 0.153 ± 0.011∗∗ 0.138 ± 0.008∗∗
Values are expressed as means ± SEM; 𝑛 = 6.
∗
𝑃 < 0.05 versus SHAM rats, ∗∗𝑃 < 0.05 versus SHAM + EP rats.
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Figure 1: Quantitative analysis of alveolar bone loss. (a) The area enclosed by the green line represents alveolar bone absorption in upper
second molar; (b) the distance from CEJ to ABC represents alveolar bone absorption. CEJ: cemento-enamel junction; ABC: alveolar bone
crest.
Table 2: Comparison of alveolar bone loss in different groups.
Groups
Area of the periodontal
ligament in the root
furcation (mm2)
Distance from the
CEJ to the ABC (mm)
SHAM 0.25 ± 0.05 0.46 ± 0.03
OVX 0.33 ± 0.07∗ 0.69 ± 0.06∗
SHAM + EP 0.35 ± 0.10 0.71 ± 0.06
OVX + EP 0.49 ± 0.12∗∗ 0.82 ± 0.07∗∗
Values are expressed as means ± SEM; 𝑛 = 6.
∗
𝑃 < 0.05 versus SHAM rats; ∗∗𝑃 < 0.05 versus SHAM + EP rats.
then mounted. Controls for the immunostaining procedures
were obtained by omitting the primary antibodies or
substitution with nonspecific antibodies. The sections were
evaluated by a single examiner who was blinded to the
treatment assignment under a microscope (1X71, Olympus
Co., Tokyo, Japan) with a camera mounted on a computer.
Three selected areas (50 × 50𝜇m) in the furcation of each
section were used to count positive stained cells.
2.8. Statistical Analysis. The quantitative data include the
distance from the CEJ to the ABC, serum cytokine concen-
trations, the area of the periodontal ligament in the root
furcation. All data were subjected to paired 𝑡-tests using
SPSS 13.0 (SPSS, Chicago, IL, USA) statistical software, and
differences were considered significant when 𝑃 < 0.05.
3. Results
3.1. Changes in theWhole Body, the Pelvis, and the Spine BMD
Levels. Compared with the SHAMgroup, the BMD of whole
body, pelvis, and spine in the OVX group decreased signif-
icantly. Compared with the SHAM + EP group, the BMD
values in the OVX + EP group also decreased significantly
(𝑃 < 0.05). Table 1 shows the BMD values in the four groups.
3.2. Histometric Results of Alveolar Bone. At 12 weeks after
the EP, the alveolar bone loss in the root furcation and
the contralateral zone increased significantly in the ovariec-
tomized rats (Figure 2). As shown in Table 2, the area of the
periodontal ligament in the root furcation in the OVX and
the OVE + EP groups was significantly bigger than that in
the SHAM and SHAM + EP groups, respectively. The same
trend was observed in the distance from the CEJ to the ABC.
3.3. Detection of Serum Cytokines. Twelve weeks after the
EP, the serum cytokines mentioned previously except BAP
were detected by enzyme-linked immunosorbent assay tech-
niques. The activity of BAP was measured by automatic
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Table 3: Detection of serum cytokines in four groups of rats.
Groups BAP (U/L) TRAP 5b (pg/L) IL-1𝛽 (ng/L) TNF-𝛼 (ng/L) IL-6 (ng/L)
SHAM 54.8 ± 7.0 1899.2 ± 256.7 22.1 ± 4.4 229.5 ± 52.2 63.8 ± 10.0
OVX 72.5 ± 8.8∗ 2245.3 ± 350.3∗ 39.0 ± 6.7∗ 293.3 ± 37.8∗ 146.0 ± 17.4∗
SHAM + EP 53.8 ± 4.2 1849.0 ± 242.6 27.3 ± 5.0 236.7 ± 55.4 77.4 ± 9.6
OVX + EP 74.7 ± 8.7∗∗ 2298.8 ± 299.1∗∗ 36.9 ± 5.2∗∗ 302.8 ± 36.8∗∗ 140.5 ± 13.23∗∗
Values are expressed as means ± SEM; 𝑛 = 6.
∗
𝑃 < 0.05 versus SHAM rats; ∗∗𝑃 < 0.05 versus SHAM + EP rats.
D
PL
AB
D
D D
D DD
D
PL
PL PL
PL
PL
PL
PL
AB AB
AB
AB
AB
AB
AB
(a) (b)
(A) (B)
(C) (D)
(A) (B)
(C) (D)
Figure 2: Histological aspect of upper second molar furcation area (a) and the distance from the CEJ to the ABC (b). A: SHAM; B: OVX; C:
SHAM + EP; D: OVX + EP. D: dentine; periodontal ligament area; PL: alveolar bone AB: (H&E, Bar = 200 𝜇m.)
Chemistry Analyzer. Increases of BAP, TRAP 5b, IL-1𝛽, TNF-
𝛼, and IL-6 were found in the group OVX compared with
that in the group SHAM. Similarly, the expression of BAP,
TRAP5b, IL-1𝛽, TNF-𝛼 and IL-6 were higher in the group
OVX + EP compared with that in the group SHAM + EP
(Table 3).
3.4. Immunohistochemical Expression of Cytokines. Immuno-
histochemical staining for IL-6, OPG, RANKL, MMP-8, and
IL-10 was carried out in the periodontal tissues and, as shown
in Figures 3 and 4, the number of cells positive for IL-6, OPG,
RANKL, and MMP-8 in the OVX and OVX + EP groups
was significantly higher than that in the SHAM and SHAM
+ EP groups, respectively (𝑃 < 0.05), whereas the number of
IL-10 positive cells in the OVX and OVX + EP groups was
significantly lower (𝑃 < 0.05) compared to that in the SHAM
and SHAM + EP groups, respectively. However, no changes
in immunohistochemical staining for IL-1𝛽 and TNF-𝛼 were
noted between these groups.
4. Discussion
Rats are commonly used as experimental animals because
the structure of periodontal tissues and the features of
PMO in rats are similar to those in humans. In addition,
ligation-induced periodontal tissue inflammation is an acute
periodontitismodel, making it a promisingmodel for investi-
gating the correlation between PMO and experimental peri-
odontitis [15–17]. Tanaka et al. found that estrogen deficiency
led to alveolar bone loss, high bone turnover rates, and
increased bone formation and resorption [15]. These results
imply that ligation-induced periodontitis in ovariectomized
rats could be an ideal model for investigating the relationship
between PMO and experimental periodontitis. In present
study, we demonstrated that the BMD of whole body, pelvis,
and spine in ovariectomized rats decreased significantly and
serum concentrations of BAP and TRAP increased after
ovariectomy. BAP and TRAP are well-established metabolic
markers for osteoblastic bone formation and osteoclastic
bone resorption, respectively [18]. In this study, elevated
serum concentrations of BAP and TRAP in ovariectomized
rats implied high levels of bone resorption and formation.
These typical osteoporosis profiles indicated that osteoporosis
model was established successfully. Moreover, the ligation-
induced experimental periodontitis exacerbated alveolar
bone loss, which confirms the previous studies that post-
menopause is a potential risk factor in the progression of
periodontitis [4–6].
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Figure 3: Immunohistochemical staining of the periodontal lig-
ament in the root furcation of upper second molar in the four
treatment groups. (Bar = 100 𝜇m.)
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Figure 4: The number of cytokine-positive cells in the periodontal
ligament in the root furcation of upper second molar in the four
treatment groups under immunohistochemical staining. The blue,
red, yellow, and green boxes represent the groups SHAM, OVX,
SHAM + EP, and OVX + EP, respectively. ∗𝑃 < 0.05 versus SHAM
rats; ∗∗𝑃 < 0.05 versus SHAM + EP rats.
Cytokines are soluble proteins which can initiate, medi-
ate, and control immune and inflammatory responses. It has
been proposed that pro- and anti-inflammatory cytokines
contribute to various bone metabolic diseases including
periodontitis and postmenopausal osteoporosis (PMO) [10,
12, 19–21]. Among the proinflammatory, the IL-1, IL-6, and
TNF-𝛼 have been reported to present fundamental role in
periodontal bone destruction [22]. In present study, we found
that the serum concentrations of IL-1𝛽, IL-6, and TNF-
𝛼 increased significantly in ovariectomized rats. Elevated
proinflammatory cytokines in the periodontal microenvi-
ronment increase the number of osteoclasts by promoting
osteoclast precursors to differentiate into osteoclasts and
extending the lifespan of osteoclasts [12, 23]. Estrogen blocks
bone loss by blocking the production of proinflammatory
cytokines in the bone marrow, bone cells, and periodon-
tal ligaments. IL-1𝛽 and TNF-𝛼 are potent promoters of
bone resorption and inhibitors of bone formation, and
IL-6 promotes the differentiation of osteoclast precursors
into osteoclast and MMP production [16, 24]. The present
study showed that the serums IL-6, IL-1𝛽, and TNF-𝛼
concentration increased significantly, but IL-1𝛽 and TNF-𝛼
in periodontal tissue were not significantly changed, which
was confirmed by immunohistochemical staining. IL-1𝛽 and
TNF-𝛼 are upstream cytokines that are key factors that induce
the production and secretion of downstream cytokines, and
their slight upregulation leads to significantly higher expres-
sion of downstream cytokines such as IL-6. On the other
hand, the lipopolysaccharide (LPS) produced by normal oral
flora promotes the production of proinflammatory cytokines
in periodontal ligament cells, endothelial cells, monocytes,
and macrophages.Therefore, estrogen deficiency upregulates
the proinflammatory cytokines produced by host cells after
ovariectomy.
Maintaining the balance of proinflammatory and anti-
inflammatory cytokines in the body is one of the manifes-
tations of self-regulation [25]. Proinflammatory cytokines
and anti-inflammatory cytokines mediate the regulation
of periodontal tissues by estrogen. Our data showed that
ovariectomy decreased the IL-10 levels in periodontal tissues,
which could increase the alveolar bone loss. As far as we
know, this is the first study to show IL-10 expression in
periodontal tissue in an animal osteoporosis model. IL-10 has
been identified as an anti-inflammatory cytokine and a B cell
proliferation factor, having protecting effects on periodontal
tissues destruction [26]. This interleukin is critical in the
initiation and progression of periodontal inflammatory [27,
28]. Clinical researches have shown that IL-10 levels in GCF
are lower in periodontitis sites, whereas the expression in
healthy sites is higher [29]. Furthermore, alveolar bone loss
is reportedly significant in IL-10 knockout mice [30, 31].
IL-10 has been shown to exert an inhibitory on alveolar
bone resorption partly through the downregulation of the
expression of IL-1𝛽, IL-6, and TNF-𝛼 [32–35]. In addition,
IL-10 is also able to inhibit MMPs and RANKL expression
and concomitantly induces the production of their respective
inhibitors TIMPs and OPG, reinforcing its potential protec-
tive role in periodontal destruction [35].
Receptor activators of nuclear factor-𝜅B (RANK),
RANK ligand (RANKL), and osteoprotegerin (OPG) are
the major regulatory proteins in osteoclastogenesis [8–11].
RANK/RANKL interactions have been shown to activate the
proliferation, differentiation, multinucleation, and survival
of osteoclasts. These stimulatory effects on bone resorption
can be prevented by OPG, a soluble neutralizing receptor
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for RANKL [11]. It is well known that OPG and RANKL are
essential for regulating osteoclast differentiation, maturation,
and lifespan, as well as bone resorption. They play an
important role in physiologic bone reconstruction and in
the pathologic processes of bone loss, such as osteoporosis
and periodontal diseases [36]. Studies on RANKL and OPG
expression demonstrated higher RANKL and lower OPG
expression levels in periodontitis, compared to healthy
gingival tissue, in line with the biological mechanisms
of these molecules in bone remodelling [37, 38]. Further
on, the effects of OPG on periodontal bone resorption
were tested in experimental periodontitis model. In this
periodontitis model, coadministration of OPG reduced
alveolar bone resorption and osteoclast formation on the
bone surface [39]. In present study, we observed that the
expression of OPG and RANKL increased after ovariectomy,
which suggests that bone turnover rate in local bone tissues
increased. In addition, RANKL increased more significantly
than OPG, indicating that ovariectomy increases alveolar
bone resorption in the root furcation area.
IL-1, IL-6, IL-10, and TNF-𝛼 regulate the expression of
OPG, RANKL, and MMP-8 in periodontal tissues [10]. It has
been reported that the regulation of LPS-induced RANKL
expression by estrogen probably occurs by inhibiting the
upregulation of upstream proinflammatory cytokines such as
IL1𝛽, IL-6, and TNF-𝛼, whereas the regulation of OPG by
estrogen is unrelated to upstream proinflammatory cytokines
[24, 34]. Whether changes in OPG, RANKL, and MMP-8 in
periodontal tissues are attributed indirectly to the changes in
IL1𝛽, IL-6, and TNF-𝛼 or due to the reductions in estrogen
is still unclear and further studies are required to better
understand the potential mechanisms of estrogen deficiency
induced periodontal destruction.
In conclusion, ovariectomy promotes alveolar bone
resorption in rats with experimental periodontitis and the
possible underlying mechanism may be due to the decreased
IL-10 and increased IL-6, OPG, and RANKL in ovariec-
tomized periodontal tissues.
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